Recent changes

Jump to navigation Jump to search

Track the most recent changes to the wiki on this page.

Recent changes options Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 00:10, 26 April 2024
   
 
List of abbreviations:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes

25 April 2024

     22:53  Reni Syndrome diffhist −3 Alara E. Dagsali talk contribs
N    22:52  User:AED‎‎ 3 changes history +3,204 [Alara E. Dagsali‎ (3×)]
     
22:52 (cur | prev) −144 Alara E. Dagsali talk contribs
     
22:51 (cur | prev) +407 Alara E. Dagsali talk contribs
N    
22:39 (cur | prev) +2,941 Alara E. Dagsali talk contribs (Created page with "==Alara Ece Dagsali== '''Alara Ece Dagsali''' <br>'''Contact:''' email: alaraecedagsai99@gmail.com; +905313614710 ==Medical Education== *School of Medicine (M.D.): Istanbul Medipol University 2021- 2024 Demiroglu Bilim University 2018-2021 ==Pages authored/Co-authored/Collaborated== ===2023=== ====Authored:==== *Reni Syndrome ==Work Experience== *Wikidoc - Associate Editor-In-Chief, 2023 - Current *Yeditepe University Hospitals Cardiac Electrophysiology Lab, Ista...")
     22:48  Adagrasib diffhist +3 Alara E. Dagsali talk contribs
     22:48  2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC) diffhist +20 Alara E. Dagsali talk contribs
     22:45  Norelgestromin diffhist +3 Alara E. Dagsali talk contribs
     22:45  Tranexamic‎‎ 6 changes history +1 [Alara E. Dagsali‎ (6×)]
     
22:45 (cur | prev) +11 Alara E. Dagsali talk contribs
     
22:44 (cur | prev) −11 Alara E. Dagsali talk contribs
     
22:41 (cur | prev) +2 Alara E. Dagsali talk contribs
     
22:41 (cur | prev) −1 Alara E. Dagsali talk contribs
     
22:40 (cur | prev) +14 Alara E. Dagsali talk contribs Tag: Manual revert
     
22:39 (cur | prev) −14 Alara E. Dagsali talk contribs Tag: Manual revert
     22:36  Alara E. Dagsali diffhist +40 Alara E. Dagsali talk contribs
N    21:21  Daprodustat‎‎ 6 changes history +6,894 [Alen Antony‎ (6×)]
     
21:21 (cur | prev) +952 Alen Antony talk contribs
     
20:53 (cur | prev) +1,266 Alen Antony talk contribs
     
19:07 (cur | prev) +2,809 Alen Antony talk contribs
     
17:23 (cur | prev) +563 Alen Antony talk contribs
     
16:47 (cur | prev) +147 Alen Antony talk contribs
N    
15:23 (cur | prev) +1,157 Alen Antony talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{AAP}} |genericName=daprodustat |aOrAn=a |drugClass=reversible inhibitor of HIF-PH1, PH2 and PH3. |indicationType=treatment |indication=anemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least four months. |hasBlackBoxWarning=Yes |adverseReactions=Hypertension, Abdominal pain, Dizzines, Hypersensitivity, and thrombotic vascular events like Myocardial infarction, stroke, pulmonary embolism,...")
 m   17:37  Non-degenerate nucleotides per response element‎‎ 2 changes history +3,020 [Marshallsumter‎ (2×)]
 m   
17:37 (cur | prev) +705 Marshallsumter talk contribs (→‎Tabulation of counts)
 m   
07:56 (cur | prev) +2,315 Marshallsumter talk contribs (→‎Tabulation of counts)
     17:03  Chronic hypertension medical therapy diffhist +715 Badgettrg talk contribs (→‎Impact of Blood Pressure self-monitoring in Hypertension Control)
     01:50  Bexagliflozin‎‎ 4 changes history +3,949 [Alen Antony‎ (4×)]
     
01:50 (cur | prev) +1,145 Alen Antony talk contribs
     
00:57 (cur | prev) +669 Alen Antony talk contribs
     
00:50 (cur | prev) +1,349 Alen Antony talk contribs
     
00:17 (cur | prev) +786 Alen Antony talk contribs